Human APOD ELISA Kit (V2LY-0626-LY4361)

Kielkopf, C. S., Whitten, A. E., Garner, B., & Brown, S. H. (2021). Small angle X-ray scattering analysis of ligand-bound forms of tetrameric apolipoprotein-D. Bioscience Reports, 41(1), BSR20201423.

Henri, P., & Rumeau, D. (2021). Ectopic expression of human apolipoprotein D in Arabidopsis plants lacking chloroplastic lipocalin partially rescues sensitivity to drought and oxidative stress. Plant Physiology and Biochemistry, 158, 265-274.

Pascua-Maestro, R., Corraliza-Gomez, M., Fadrique-Rojo, C., Ledesma, M. D., Schuchman, E. H., Sanchez, D., & Ganfornina, M. D. (2020). Apolipoprotein D-mediated preservation of lysosomal function promotes cell survival and delays motor impairment in Niemann-Pick type A disease. Neurobiology of Disease, 144, 105046.

Jankovic‐Karasoulos, T., Bianco‐Miotto, T., Butler, M. S., Butler, L. M., McNeil, C. M., O’Toole, S. A., ... & Ricciardelli, C. (2020). Elevated levels of tumour apolipoprotein D independently predict poor outcome in breast cancer patients. Histopathology, 76(7), 976-987.

Kuiperij, H. B., Hondius, D. C., Kersten, I., Versleijen, A. A. M., Rozemuller, A. J. M., Greenberg, S. M., ... & Verbeek, M. M. (2020). Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy. Neuropathology and applied neurobiology, 46(5), 431-440.

Bhatia, S., Kim, W. S., Shepherd, C. E., & Halliday, G. M. (2019). Apolipoprotein D upregulation in Alzheimer’s disease but not frontotemporal dementia. Journal of Molecular Neuroscience, 67(1), 125-132.

Yu, R. H., Zhang, X. Y., Xu, W., Li, Z. K., & Zhu, X. D. (2020). Apolipoprotein D alleviates glucocorticoid-induced osteogenesis suppression in bone marrow mesenchymal stem cells via the PI3K/Akt pathway. Journal of Orthopaedic Surgery and Research, 15(1), 1-8.

Salami, M., Bandegi, A. R., Sameni, H. R., Vafaei, A. A., & Pakdel, A. (2019). Hippocampal up-regulation of apolipoprotein D in a rat model of maternal hypo-and hyperthyroidism: implication of oxidative stress. Neurochemical research, 44(9), 2190-2201.

Waldner, A., Dassati, S., Redl, B., Smania, N., & Gandolfi, M. (2018). Apolipoprotein D concentration in human plasma during aging and in Parkinson’s disease: a cross-sectional study. Parkinson’s Disease, 2018.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols